Press Releases
H.E.L Group expands range of BioXplorer bioreactors to support bioprocess development
8 June 2023 -- London, UK -- H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, safety and scale-up, today expanded its BioXplorer range with the introduction of two new automated parallel bioreactors: BioXplorer 400XL and BioXplorer 400P. The new systems will further enable the efficient and cost-effective development and optimisation of bioprocesses.
The BioXplorer 400P is designed for use at pressures up to 10 bar, allowing for increased cell density and product yields. Optimised for syngas fermentation, the BioXplorer 400P combines easy to use software with modular hardware to give complete control of four high-pressure bioprocesses simultaneously. The BioXplorer 400 XL features 8 configurable bioreactors, which can be controlled independently or in parallel. Its modular design allows accurate and precise additions of liquids and gases, controlled by up to four sets of peristaltic pumps and up to two sets of mass flow controllers respectively, with software enabling control of all eight bioprocesses at once. Both bioreactors are available for use with either magnetic or direct agitation, to support enhanced cell densities and product yield.
The full range of H.E.L bioreactor systems allow automated, parallel experimentation in sizes ranging from 50ml to 5L, with applications in research into gas fermentation and bio-production at a bench-scale. Ideal for small-scale process development and cell line/strain screening, the flexible and adaptable bioreactors are suitable for research, screening and optimisation investigations.
Louise Madden, CEO at H.E.L Group, said: “Our flexible bioreactor systems help our customers gain more knowledge about their bioprocesses earlier in their development and so make better decisions, resulting in bioprocess development which is faster and more productive. The introduction of the new BioXplorer 400P and BioXplorer 400XL further increases our automated parallel bioreactor offering, doubling volume capabilities with highly configurable and readily upgradable systems.”
About H.E.L Group
H.E.L Group's mission is to work together with chemistry, safety and biotechnology experts to engineer and unleash the full potential of the scientific community. To this end, H.E.L develops and manufactures innovative scientific instruments and software designed to optimise the efficiency, safety and productivity of key processes in chemistry and biology applications. The H.E.L team of over 80 includes highly skilled process and software engineers, based at their extensive research and manufacturing facilities in the UK, as well as sales and support offices around the world. H.E.L has a long history of solving complex challenges for customers. For more than 30 years, the company has worked with businesses and laboratories globally, providing proprietary automated solutions for the pharma, biotechnology, chemical, battery and petrochemical sectors. Following significant growth, and with annual revenues exceeding £10m, the company is extending the reach of its products to support and enable R&D and process optimisation further across the US, China, Asia-Pacific and India. Visit: www.helgroup.com.
- Automated parallel bioreactor offering updated with increased capabilities for multi-parameter process development
- BioXplorer systems are modular and highly configurable with automation, process control, safety monitoring and data recording enabled through control software
8 June 2023 -- London, UK -- H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, safety and scale-up, today expanded its BioXplorer range with the introduction of two new automated parallel bioreactors: BioXplorer 400XL and BioXplorer 400P. The new systems will further enable the efficient and cost-effective development and optimisation of bioprocesses.
The BioXplorer 400P is designed for use at pressures up to 10 bar, allowing for increased cell density and product yields. Optimised for syngas fermentation, the BioXplorer 400P combines easy to use software with modular hardware to give complete control of four high-pressure bioprocesses simultaneously. The BioXplorer 400 XL features 8 configurable bioreactors, which can be controlled independently or in parallel. Its modular design allows accurate and precise additions of liquids and gases, controlled by up to four sets of peristaltic pumps and up to two sets of mass flow controllers respectively, with software enabling control of all eight bioprocesses at once. Both bioreactors are available for use with either magnetic or direct agitation, to support enhanced cell densities and product yield.
The full range of H.E.L bioreactor systems allow automated, parallel experimentation in sizes ranging from 50ml to 5L, with applications in research into gas fermentation and bio-production at a bench-scale. Ideal for small-scale process development and cell line/strain screening, the flexible and adaptable bioreactors are suitable for research, screening and optimisation investigations.
Louise Madden, CEO at H.E.L Group, said: “Our flexible bioreactor systems help our customers gain more knowledge about their bioprocesses earlier in their development and so make better decisions, resulting in bioprocess development which is faster and more productive. The introduction of the new BioXplorer 400P and BioXplorer 400XL further increases our automated parallel bioreactor offering, doubling volume capabilities with highly configurable and readily upgradable systems.”
About H.E.L Group
H.E.L Group's mission is to work together with chemistry, safety and biotechnology experts to engineer and unleash the full potential of the scientific community. To this end, H.E.L develops and manufactures innovative scientific instruments and software designed to optimise the efficiency, safety and productivity of key processes in chemistry and biology applications. The H.E.L team of over 80 includes highly skilled process and software engineers, based at their extensive research and manufacturing facilities in the UK, as well as sales and support offices around the world. H.E.L has a long history of solving complex challenges for customers. For more than 30 years, the company has worked with businesses and laboratories globally, providing proprietary automated solutions for the pharma, biotechnology, chemical, battery and petrochemical sectors. Following significant growth, and with annual revenues exceeding £10m, the company is extending the reach of its products to support and enable R&D and process optimisation further across the US, China, Asia-Pacific and India. Visit: www.helgroup.com.
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.